博客

其他健康状况

了解 Ilumya:用途、副作用和定价

Psoriasis and Ilumya medical concept image

Ilumya injection is FDA-approved to treat adults with moderate-to-severe 斑块状银屑病. If you or anyone you love is living with plaque psoriasis, this article will cover everything you need to know about this medication, including its uses, mechanism, dosage, side effects, and cost. 

获得经济援助

(877) 778-0318

Important Ilumya Warnings

Increased Risk of Infection

This medication may suppress your immune system, increasing the risk of infections. Before starting treatment, your healthcare provider will order tests to see if you have an infection or tuberculosis (TB). 

If you have active TB or have had it in the past, your healthcare provider may treat you for TB before starting treatment. 

Call your healthcare provider right away if you have the following signs of infection:

  • Fever, sweats, or chills
  • 咳嗽
  • 气促
  • Blood in your mucus
  • 肌肉酸痛
  • Warm, red, or painful skin or sores that aren’t due to psoriasis
  • 体重减轻
  • 腹泻 
  • 胃痛
  • Burning during urination 
  • Increased urine output

Before Taking Ilumya

Before you receive the first dose, inform your healthcare provider if you:

  • Have a history of allergy to this product or any product components. 
  • Have long-term (chronic) or recurrent infection.
  • Have TB, or someone close to you has been diagnosed with TB.
  • Have recently been vaccinated or are scheduled to get vaccinated. You shouldn’t receive live vaccines during the treatment period. Live vaccine examples include MMR (measles, mumps, rubella), chickenpox, and nasal spray flu vaccines. 

Ilumya Introduction and Uses

Ilumya is a brand-name prescription medication. Generic versions aren’t available. 

The active ingredient in this product is tildrakizumab-asmn, which is in a category of targeted drug therapies called monoclonal antibodies. 

Monoclonal antibodies are lab-created immune system proteins that can suppress, mimic, or enhance your immune response. 

In March 2018, the US FDA approved this product to treat moderate-to-severe plaque psoriasis. Adults who may benefit from systemic therapy (oral or injectable medicine) or light therapy are considered for Ilumya therapy. 

Plaque psoriasis is an autoimmune disorder characterized by thick, scaly patches on the elbows, back, knees, and scalp. In severe cases, the patches may affect the entire body. 

立即获得共付额援助

开始

Ilumya Mechanism of Action

Ilumya directly blocks the action of a protein, IL-23, which plays a crucial role in inflammatory and immune responses. By blocking IL-23, Ilumya:

  • Helps balance an overactive immune response. 
  • Decreases the buildup of inflammatory cells in the skin. 
  • Stops the formation of scaly patches. 

As a result, the skin becomes clearer, less inflamed, and less itchy. Clinical studies show that nearly 60% of individuals who use Ilumya have minimal or no symptoms after 3 months.

Ilumya Dosage

This medication comes as a clear to slightly yellow liquid to be injected under the skin (subcutaneous/SC). 

The following strength is available in the US: 100 mg/ml solution in a single-dose prefilled syringe.

Your healthcare provider or a nurse administers Ilumya injection into the stomach area, thigh, or upper arm. The first dose is 100 mg SC. The second dose is 100 mg SC after 4 weeks. Then, 100 mg SC is administered every 12 weeks. 

笔记: You shouldn’t self-administer the Ilumya injection. 

Ilumya Side Effects

常见副作用

Illumya patient suffering from plaque psoriasis

Call your healthcare provider if the following symptoms worsen or don’t go away. 

  • 上呼吸道感染
  • Injection site reactions (pain, swelling, or bleeding at the injection site)
  • 腹泻

过敏反应

如果您遇到以下情况,请寻求紧急医疗护理:

  • A feeling like you’re going to pass out
  • Swelling of your face, eyelids, lips, mouth, tongue, or throat
  • A skin rash
  • 呼吸困难 
  • Throat or chest tightness

怀孕和哺乳期间使用 

Due to limited data regarding Ilumya use in pregnant women, it’s impossible to say if the drug will harm the unborn baby. Also, it’s unknown if this medication makes it harder for women to get pregnant. 

Ilumya may pass from the mother to the unborn baby. However, the impact on the mother or unborn baby is unknown. 

Animal reproduction studies haven’t reported a higher risk of miscarriage or birth defects with use during pregnancy [1].

No data are available about use during breastfeeding. Because tildrakizumab is a large protein, it’s unlikely to pass into breast milk. However, the medication was detected in breast milk in animal studies. 

漏服剂量

If you miss an appointment with your healthcare provider to receive your dose of Illumya, schedule another appointment as soon as possible.

过量

In overdose cases, seek emergency medical attention or call the poison help line at 1-800-222-1222.

与专家交谈

关于共付额援助
(877) 778-0318

Ilumya Cost

1 unit (100 mg/ml SC solution) costs around $19,000. 

However, the cost can vary depending on your insurance plan, location, and pharmacy. Contact your insurance provider to find out if your plan covers this medication or if you need prior authorization.

Sun Pharmaceutical Industries, Inc., the manufacturer of Ilumya, provides financial support if you’re eligible. 

Those with commercial insurance may enroll in the ILUMYA SUPPORT LIGHTING THE WAY® program and pay $0 for each dose with the copay card.

For those without commercial insurance, ILUMYA SUPPORT LIGHTING THE WAY® may help by connecting them to a dedicated support specialist.

The cost of a prescription may be $0 for those who have Medicare Part B with supplemental insurance.

联系我们 if you are interested in exploring financial assistance options for Ilumya. 

Ilumya vs. Skyrizi

While both Ilumya and Skyrizi are used to treat moderate-to-severe plaque psoriasis, they differ in several ways. Below are some of the differences:

IlumyaSkyrizi
FDA approval date20182019
Active drugtildrakizumabrisankizumab
Who can administer?Only a healthcare professionalSelf-administration after training
Available strength100 mg75 mg 
Approved usesModerate-to-severe plaque psoriasis in adultsModerate-to-severe plaque psoriasis, active psoriatic arthritis, 克罗恩病, and ulcerative colitis in adults

参考:

  1. MotherToBaby | Fact Sheets [Internet]. Brentwood (TN): Organization of Teratology Information Specialists (OTIS); 1994-. Tildrakizumab (Ilumya®) 2023 Feb. Available from: https://www.ncbi.nlm.nih.gov/books/NBK582978/
此信息不能替代医疗建议或治疗。在开始任何新的治疗之前,请咨询您的医生或医疗保健提供者,了解您的医疗状况。AmeriPharma® Specialty Care 对所提供的信息或由此做出的任何诊断或治疗不承担任何责任,也不对其内容的可靠性负责。AmeriPharma® Specialty Care 并非运营此处列出的所有网站/组织,也不对其内容的可用性或可靠性负责。这些列表并不暗示或构成 AmeriPharma® Specialty Care 的认可、赞助或推荐。本网页可能包含对品牌处方药的引用,这些处方药是与 AmeriPharma® Specialty Care 无关的制药商的商标或注册商标。
Dr. Mark Alfonso
医学审核人 Mark Alfonso 博士,药学博士,BCMTMS

Mark Alfonso 博士,药学博士,在科罗拉多州普韦布洛出生长大。他于 2010 年在科罗拉多大学安舒茨医学院药学院获得药学学位。他于 2022 年获得药物治疗管理委员会认证。他工作中最有成就感的部分是帮助解答患者的疑问和担忧。他的专业领域是社区药房和药物治疗管理。闲暇时,他喜欢阅读和跑步。

联系我们

使用下方符合 HIPAA 标准的表格申请续药。如果您对药物或用药方法有任何疑问,请访问“联系我们”页面或致电 (877) 778-0318.

HIPAA Compliant

提交即表示您同意 AmeriPharma 的 使用条款, 隐私政策, 和 隐私惯例通知

zh_CNChinese